Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Systemic Light Chain Amyloidosis Clinical Trials

2 recruiting trials for Systemic Light Chain Amyloidosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT07151690

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

This is a prospective, single-arm, single-center clinical study designed to evaluate the efficacy and safety of low-dose BCMA/CD3 bispecific antibody (CM336) in patients newly...

Sponsor: Institute of Hematology & Blood Diseases Hospital, ChinaEnrolling: 211 location
RECRUITINGPhase 1 / Phase 2NCT07266116

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain...

This study is a clinical trial aimed at the marketing of TQB2934 for injection. The project plans to enroll 70 subjects, including 13-21 subjects in Phase Ib, to evaluate the...

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Enrolling: 7020 locations